Patients' Acceptance of COVID-19 Vaccine: Implications for Patients with Chronic Disease in Low-Resource Settings

Firomsa Bekele1, Ginenus Fekadu2,3, Tarekegn Fekede Wolde4

  • 1Department of Pharmacy, College of Health Science, Mettu University, Mettu, Ethiopia.

Insights

Vaccine hesitancy is a global health threat, especially for chronic disease patients in low-income countries due to limited information. More research is needed on COVID-19 vaccine acceptance in these vulnerable populations.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Coronavirus disease 2019 (COVID-19) presents a significant global health challenge with high morbidity and mortality.
  • Despite vaccine development, uncontrolled virus spread persists, exacerbated by vaccine shortages in low-income nations.
  • Vaccine hesitancy, particularly among individuals with chronic diseases, poses a major threat to global health efforts.

Purpose of the Study:

  • To address the lack of information and persistent misconceptions surrounding COVID-19 vaccination.
  • To investigate the factors influencing COVID-19 vaccine acceptance among chronic disease patients in low-resource settings.
  • To advocate for wider studies on vaccine acceptance in vulnerable populations.

Main Methods:

  • This study focuses on analyzing existing evidence and identifying knowledge gaps.
  • Qualitative and quantitative research methods will be employed to assess vaccine perceptions.
  • Surveys and interviews will be conducted with chronic disease patients in selected low-resource settings.

Main Results:

  • Preliminary findings indicate significant fear and uncertainty regarding COVID-19 vaccines among chronic disease patients.
  • Information scarcity is a primary driver of vaccine hesitancy in these populations.
  • Existing misconceptions about vaccine safety and efficacy are prevalent.

Conclusions:

  • Addressing misinformation and improving vaccine accessibility are crucial for increasing acceptance.
  • Targeted health education campaigns are needed for chronic disease patients in low-resource settings.
  • Further research is essential to understand and overcome barriers to COVID-19 vaccine uptake in vulnerable groups.

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
18
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
197
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
148